Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1742)	2/7/2001 12:39:06 PM
From: Andy Blaher	Respond to of 1837

This company has always been hard to figure from a coverage standpoint. You know there are analysts who are aware of the existence of DRMD because of their participation in past conference calls. They can see the potential market, as you said, the numbers are finally beginning to look good and still nada. Perhaps they have simply traded away too much of their potential to their partners. But until this stock gets some coverage, I don't see a whole lot of movement. Although it is nice to see it finally headed, albeit slowly, in the right direction.